Most clinical trials involve a variety of laboratory vendors and CROs to provide services during the course of the study. Disparity in how each vendor handles, tracks and reports its data can present a challenge.
In this episode, Barbara Nagaraj, Senior IT Architect at BioFortis, a IQVIA Laboratories company, describes those challenges and how to mitigate them by asking the right questions in advance.
Barbara talks about:
- The need to harmonize data moving between systems
- How to approach vendors of different sizes and capabilities
- The best time to engage a vendor about data management
- Questions to be answered in negotiations
- A success story that saves a lot of time and effort
To learn more, visit www.q2labsolutions.com/labmatrix
Related Insights
Managing Informed Consent Samples from Clinical Trials
A set of best practices for the definition, tracking and management of allowable use attributes associated with samples collected in protocol based clinical trials
Consent Tracking for Clinical Trial Samples
Optimizing the management of consents throughout the entire lifecycle
Tracking Clinical Trial Samples
Optimizing the management of samples throughout the entire lifecycle
Blockchain in Clinical Research Sample Management
Distributed Ledger Technology (DLT) in clinical trials
Using Labmatrix® at a Big Biopharma Company to Reduce Clinical Trial Delays, Costs and Regulatory Risks
Managing Sample Data from Vendors
Best practices for clinical trials
eConsent and BioBanking
How to reduce costs while improving efficiencies
Key Central Laboratory Capabilities to Enable Successful Immuno-Oncology Clinical Development
Trends and recommendations in laboratory selection
Best practices in clinical trial sample and consent lifecycle management
Clinical Trial Biospecimen and Consent Tracking
Learn about the BioFortis solution for addressing new challenges around sample and consent tracking
